ArnstenAFT: Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: An important role for prefrontal cortex dysfunction. CNS Drugs, 23(1): 33–41, 2009.
2.
BarkleyRA: Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychol Bull, 121: 65–94, 1997.
3.
BiedermanJ, MelmedRD, PatelA, McBurnettK, KonowJ, LyneA, SchererN, GroupSS: A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics, 121: e73–e84, 2008.
4.
BiedermanJ, SpencerT, LomedicoA, DayH, PettyCR, FaraoneSV: Deficient emotional self-regulation and pediatric attention deficit hyperactivity disorder: A family risk analysis. Psychol Med, 42: 639–646, 2011.
5.
ConnerDF, GrassoDJ, SlivinskyMD, PearsonGS, BangaA: an open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents. J Child Adol Psychop, 23: 244–251, 2013.
6.
GajriaK, LuM, SikiricaV, GrevenP, ZhongY, QinP, XieJ: Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder—A systematic literature review. Neuropsychiatr Dis Treat, 10: 1543–1569, 2014.
7.
NiggJT, CaseyBJ: An interactive theory of attention-deficit/hyperactivity disorder based on the cognitive and affective neurosciences. Dev Psychopathol, 17: 785–806, 2005.
8.
SobanskiE, BanaschewskiT, AshersonP, BuitelaarJ, ChenW, FrankeB, HoltmannM, KrummB, SergeantJ, Sonuga-BarkeE, StringarisA, TaylorE, AnneyR, EbsteinRP, GillM, MirandaA, MulasF, OadesRD, RoeyersH, RothenbergerA, SteinhausenHC, FaraoneSV: Emotional lability in children and adolescents with attention-deficit/hyperactivity disorder (ADHD): Clinical correlates and familial prevalence. J Child Psychol Psyc, 51:15–23, 2010.
9.
SpencerT, FaraoneSV, SurmanCBH, PettyC, ClarkeA, BatchelderH, WozniakJ, BiedermanJ: Towards defining deficient emotional self regulation in youth with attention deficit hyperactivity disorder using the child behavior check list: A controlled study. Postgrad Med, 123: 50–59, 2011.
10.
U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Intuniv NDA 22037 approval letter, September2, 2009.
11.
WenderPH: Attention-Deficit Hyperactivity Disorder in Adults. Oxford University Press: New York, 1995.
